This is a comprehensive U.S. resource on COVID-19 related issues for leaders of UK/European private technology, life sciences, and growth companies with U.S. operations or other U.S. business interests. Topics covered include CARES Act loan programs, employee matters, tax relief, fundraising, commercial contracts, debt transactions, FDA guidance, patent filings and post-grant proceedings, and more.
Please see full publication below for more information.